SCHEMBL7613495

SCHEMBL7613495

CC(C(=O)O)c1c(OP(=O)(O)Cc2ccccc2)ccc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCEH1 Q6PIU2 3/20 0.41
HTT P42858 3/20 0.40
NPSR1 Q6W5P4 3/20 0.40
GAA P10253 1/20 0.40
GPR55 Q9Y2T6 1/20 0.40
AKR1B1 P15121 2/20 0.39
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
RECQL P46063 1/20 0.37
ACP3 P15309 2/20 0.37
ALDH1A1 P00352 1/20 0.36
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7611156 0.86 HTT (0.39) NCEH1HTTNPSR1GAAGPR55
SCHEMBL7605243 0.84 HTT (0.38) NCEH1HTTNPSR1GAAGPR55
SCHEMBL7608438 0.82 CETP (0.39) NCEH1HTTNPSR1GAAGPR55
SCHEMBL7608625 0.77 ALDH1A1 (0.50) NCEH1GAAAKR1B1KMT2AMEN1
SCHEMBL9860824 0.76 MAPT (0.50) NCEH1HTTGAAAKR1B1KMT2A
SCHEMBL10338495 0.76 MAPT (0.50) NCEH1HTTGAAAKR1B1KMT2A
SCHEMBL7607490 0.76 AKR1B1 (0.39) NCEH1HTTNPSR1GAAGPR55
SCHEMBL7609961 0.75 MEN1 (0.38) GAAKMT2AMEN1RECQLALDH1A1
SCHEMBL8459317 0.75 KMT2A (0.45) NCEH1KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL8058577 0.75 CYP1A2 (0.41) NCEH1GAAAKR1B1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002515040-A 2002-05-21 JP claimed
JP-2002514160-A 2002-05-14 JP claimed
EP-0954295-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-11-10 EP claimed
EP-0936914-A4 1999-08-25 EP claimed
EP-0936914-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-08-25 EP claimed
WO-1997048400-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO claimed
WO-1997048409-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO claimed